Ohlstein E H, Storer B, Nambi P, Given M, Lippton H
Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.
Thromb Res. 1990 Mar 15;57(6):967-74. doi: 10.1016/0049-3848(90)90163-7.
The effects of newly discovered vasoconstrictor peptide endothelin was studied on human, rabbit and canine platelet function. Endothelin (0.01 nM-1 microM) did not promote platelet aggregation. In human platelets, endothelin (0.1 microM) did not significantly affect aggregation responses to ADP, collagen, epinephrine, arachidonic acid, PGH2 or thrombin. Endothelin did not promote the mobilization of intracellular calcium in Fura2 loaded human platelets. In rabbit and canine platelets endothelin produced significant potentiation of platelet aggregation mediated by low concentrations of ADP. Aggregation responses to higher concentration of ADP (5 microM) were unaffected by endothelin. These data reveal that under certain circumstances endothelin may potentiate rabbit and canine platelet aggregation responses to ADP, however endothelin does not produce direct effects on human platelet function.
研究了新发现的血管收缩肽内皮素对人、兔和犬血小板功能的影响。内皮素(0.01 nM - 1 microM)不促进血小板聚集。在人血小板中,内皮素(0.1 microM)对ADP、胶原、肾上腺素、花生四烯酸、PGH2或凝血酶的聚集反应无显著影响。内皮素不促进负载Fura2的人血小板内钙的动员。在兔和犬血小板中,内皮素显著增强低浓度ADP介导的血小板聚集。对较高浓度ADP(5 microM)的聚集反应不受内皮素影响。这些数据表明,在某些情况下,内皮素可能增强兔和犬血小板对ADP的聚集反应,然而内皮素对人血小板功能无直接影响。